Shapiro 2000.

Methods	Randomised, placebo‐controlled trial in US
Participants	76 young children with focal epilepsy
Interventions	Syrup formulation of gabapentin 40 mg/kg/day given TDS or placebo
Outcomes	Main outcome was seizure reduction. Concluded that gabapentin was safe and well tolerated, and reduced the rate of focal seizures; however, this finding did not reach significance
Notes	All information taken from abstract, unable to contact study authors

SD: standard deviation; TDS: three times daily.